Features Screener Stocks Charts
Sign In Sign Up

Lupin Ltd. Cash Flow Statement

NSE:LUPIN | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.75x

LUPIN's operating cash flow covered 75% of net income in FY 2025. Some earnings may be tied up in working capital.

Free Cash Flow

₹13.18B

LUPIN's free cash flow was ₹13.18B in FY 2025, down 48.6% from FY 2024.

Dividend Coverage

3.6x

LUPIN's free cash flow covered dividends 3.6x in FY 2025, leaving room for reinvestment or debt reduction.

CapEx Intensity

56.1%

Capital expenditure was 56.1% of operating cash flow in FY 2025 for LUPIN, a moderate level of reinvestment.

2-year LUPIN cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 24.22B 40.15B
Cash flow Operating Activities 34.90B 30.00B
Investments in PPE -9.29B -16.82B
Cash flow Investing Activities -15.54B -41.72B
Dividend Paid -1.83B -3.65B
Cash flow Financing Activities -21.84B 17.32B
Cash at beginning of period 12.32B 9.84B
Cash at end of period 9.84B 15.44B
Free Cash Flow 25.62B 13.18B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025